IRF4 and lymphoma: In contrast, the genome-wide and DNA-based nature of Hi-C allows it to detect these types of genomic rearrangements, as exemplified in a recent case study where Arima Genomics’ Hi-C detected an IGH::IRF4 rearrangement in a lymphoma specimen.